Results 131 to 140 of about 4,446,831 (170)

Fixed-Level Frequency Threshold Testing for Ototoxicity Monitoring

Ear & Hearing, 2017
Objectives: Hearing loss from ototoxicity is often most pronounced at high frequencies. To improve patient monitoring and compliance, high-frequency testing methods should be short and easy to administer. We evaluated the repeatability and accuracy of a Békésy-like, fixed-level frequency threshold (FLFT) technique.
C. Rieke, O. Clavier, Lindsay Allen, A. Anderson, Chris A Brooks, A. Fellows, D. Brungart, J. Buckey   +7 more
semanticscholar   +3 more sources

Challenges in ototoxicity monitoring in the pediatric oncology population.

Journal of the American Academy of Audiology, 2014
Background:Platinum-based chemotherapy and cranial radiation are effective treatment options commonly prescribed for a variety of childhood cancers. These therapies can, and often do, result in early- and late-onset adverse health effects such as hearing loss.
J. Bass, Shaum P. Bhagat
semanticscholar   +3 more sources

Ototoxicity Monitoring: Program Approaches and Considerations

Seminars in Hearing, 2011
Dawn Konrad-Martin, Jane S Gordon, Marilyn F Dille   +2 more
exaly   +2 more sources

Audiologic Monitoring for Ototoxicity

Otolaryngologic Clinics of North America, 1993
In summary, the clinician has a variety of protocols available for monitoring ototoxicity. Depending on the patient's risk factors and ability to be tested, the protocol for a given patient may vary. A flow chart reflecting some of the possible decisions and options is presented in Figure 1.
K C, Campbell, J, Durrant
openaire   +2 more sources

Audiometric monitoring of cis-platinum ototoxicity

Gynecologic Oncology, 1983
A prospective study was performed on 37 patients receiving 50 mg/m2 of cis-platinum every 3 to 4 weeks. These patients received a baseline audiogram evaluation and subsequent testing before each dose. Ototoxicity was noted to occur in 46% of the patients during therapy. Fourteen percent of this group showed a hearing loss in the speech frequency range.
R L, Brown, R C, Nuss, R, Patterson, J, Irey   +3 more
openaire   +2 more sources

Vestibular Ototoxicity: The Importance and Pragmatics of Monitoring

Seminars in Hearing, 2011
exaly   +2 more sources

Ototoxicity: mechanisms, protective agents, and monitoring

Current Opinion in Otolaryngology & Head and Neck Surgery, 2000
In the past year, progress has been made not only in elucidating the mechanisms of ototoxicity but also in finding otoprotective agents. For aminoglycosides, new dosing protocols and protective agents, including growth factors and salicylates, show promise for eventually reducing ototoxicity ...
Kathleen C.M. Campbell, James Kalkanis, F. Robert Glatz   +2 more
openaire   +1 more source

Prevailing Practices in Ototoxicity Monitoring in Individuals With Head and Neck Cancer Undergoing Radiotherapy and Chemoradiotherapy: A Scoping Review.

American Journal of Audiology
PURPOSE The aim of the current scoping review is to identify the studies reporting ototoxicity monitoring in individuals with head and neck cancer (HNC) undergoing radiation therapy and/or chemoradiation therapy across the world.
V. Shankar, Jayashree Seethapathy, Satish Srinivas, Raghu Nandhan, P. Saravanam   +4 more
semanticscholar   +1 more source

High-Frequency Monitoring for Early Detection of Cisplatin Ototoxicity

Archives of Otolaryngology - Head and Neck Surgery, 1993
Cisplatin can cause irreversible hearing loss initially detectable as impairment of high-frequency hearing with progression to lower frequencies. Many patients receiving cisplatin are too ill to tolerate lengthy audiometric testing. Therefore, a rapid and sensitive high-frequency monitoring strategy to detect cisplatin-induced ototoxicity is needed ...
S A, Fausti, J A, Henry, H I, Schaffer, D J, Olson, R H, Frey, G C, Bagby   +5 more
openaire   +2 more sources

Monitoring of Cisplatin Ototoxicity by Distortion-Product Otoacoustic Emissions

Auris Nasus Larynx, 1996
Cisplatin is one of the most commonly used chemotherapeutic agents. However, ototoxicity, in particular, damage to the outer hair cells of the cochlea, is one of its major side effects. Otoacoustic emissions are acoustical signals that originate from the contractile activity of the outer hair cells. They are transmitted from the cochlea to the external
O, Ozturan, J, Jerger, H, Lew, G R, Lynch   +3 more
openaire   +2 more sources